Drugmakers should 'rethink' supply chain logistics

With COVID-19 vaccine-makers pivoting production as the virus mutates, Jim Cafone, Pfizer's senior vice president of global supply chain, said it is time for pharmaceutical companies to redevelop their logistic strategies, The Wall Street Journal reported Sept. 24.

Mr.Cafone said the race in 2020 to develop, test and deploy a safe and effective COVID-19 vaccine presented a new route for drugmakers to take during public health emergencies.

"Nobody builds a network for a pandemic, and how do you then start to wean yourself off of that and start to build your network for an endemic world but with the ability to rapidly ramp or rapidly de-escalate?" Mr. Cafone said during the annual Council of Supply Chain Management Professionals conference.

Read full article at Beckers Hospital review

https://www.beckershospitalreview.com/supply-chain/pfizer-executive-drugmakers-should-rethink-supply-chain-logistics.html